Cellectar Biosciences, Inc. (CLRB) Operating income 2016–2025
Cellectar Biosciences, Inc. (CLRB) annual operating income history from SEC filings — each fiscal year as reported.
-$23.0MFY2025 · since FY2016: -$9.4M → -$23.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.0M | +55.6% |
| FY2024 | -$51.8M | -32.9% |
| FY2023 | -$39.0M | -35.2% |
| FY2022 | -$28.8M | -19.4% |
| FY2021 | -$24.1M | -57.8% |
| FY2020 | -$15.3M | -7.8% |
| FY2019 | -$14.2M | -6.4% |
| FY2018 | -$13.3M | +2.0% |
| FY2017 | -$13.6M | -43.9% |
| FY2016 | -$9.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLRB financial trends
CLRB RevenueCLRB Net incomeCLRB Net marginCLRB Gross profitCLRB Gross marginCLRB Operating marginCLRB Operating cash flowCLRB Free cash flowCLRB Capital expendituresCLRB Return on equityCLRB Stock buybacksCLRB Dividends paidCLRB Total assetsCLRB Total liabilitiesCLRB Shareholders’ equityCLRB overview →